NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$36.15
-2.33 (-6.06%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+16.8% upside
Low Target
$31.85
Average Target
$42.23
High Target
$63.47
Current Price
$36.15
Current
$36.15
$36.15
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Scenario Analysis
Bear Case
$31.85
-11.9%
Low target
Base Case
$42.23
+16.8%
Avg target
Bull Case
$63.47
+75.6%
High target
Risk/Reward
6.4x
Highly favorable
Price in Context
52-Week High
$109.00
-66.8% from high
52-Week Low
$33.40
+8.2% from low
Target vs 52W High
$42.23
-61.3% vs high
Next Earnings Report
Nov 12, 2026 · After Market Close
4d
until earnings
EPS Est: $-2.11
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals